Biotech firms outsource to Asia
Global credit crunch forces industry's Western leaders to look east to cut costs.
The global financial crisis has hurt biotechnology, an industry in which it can take a billion dollars and 10 years to create a marketable medicine. But a survey of worldwide industry trends suggests that the funding shortage hitting North American and European market leaders could benefit emerging biotech clusters in Singapore, India and China. Full Story »
Posted by Kaizar Campwala
